Department of Otolaryngology-Head & Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Otolaryngology-Head & Neck Surgery, Icahn School of Medicine at Mount Sinai.
Otol Neurotol. 2020 Mar;41(3):290-298. doi: 10.1097/MAO.0000000000002507.
It is estimated over 466 million people worldwide have disabling hearing loss, and untreated hearing loss is associated with poorer health outcomes. The influence of sex as a biological variable on hearing loss is not well understood, especially for differences in underlying mechanisms which are typically elucidated through non-clinical research. Although the inclusion of sex as a biological variable in clinical studies has been required since 1993, sex reporting has only been recently mandated in National Institutes of Health funded non-clinical studies.
This article reviews the literature on recent non-clinical and clinical research concerning sex-based differences in hearing loss primarily since 1993, and discusses implications for knowledge gaps in the translation from non-clinical to clinical realms.
The disparity between sex-based requirements for non-clinical versus clinical research may inhibit a comprehensive understanding of sex-based mechanistic differences. Such disparities may play a role in understanding and explaining clinically significant sex differences and are likely necessary for developing robust clinical treatment options.
据估计,全球有超过 4.66 亿人患有听力损失,而未经治疗的听力损失与更差的健康结果有关。性别作为生物学变量对听力损失的影响尚不清楚,特别是对于潜在机制的差异,这些差异通常通过非临床研究来阐明。尽管自 1993 年以来,临床研究中就要求将性别作为生物学变量纳入,但直到最近,美国国立卫生研究院资助的非临床研究才强制要求报告性别。
本文主要回顾了自 1993 年以来非临床和临床研究中关于听力损失的性别差异的文献,并讨论了将非临床研究转化为临床领域的知识空白的意义。
非临床与临床研究中基于性别的要求之间的差异可能会阻碍对基于性别的机制差异的全面理解。这种差异可能在理解和解释临床上显著的性别差异方面发挥作用,并且对于开发强大的临床治疗方案可能是必要的。